Klaus Seppi

39.7k total citations · 8 hit papers
296 papers, 21.1k citations indexed

About

Klaus Seppi is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Klaus Seppi has authored 296 papers receiving a total of 21.1k indexed citations (citations by other indexed papers that have themselves been cited), including 254 papers in Neurology, 97 papers in Cellular and Molecular Neuroscience and 34 papers in Neurology. Recurrent topics in Klaus Seppi's work include Parkinson's Disease Mechanisms and Treatments (230 papers), Neurological disorders and treatments (165 papers) and Genetic Neurodegenerative Diseases (78 papers). Klaus Seppi is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (230 papers), Neurological disorders and treatments (165 papers) and Genetic Neurodegenerative Diseases (78 papers). Klaus Seppi collaborates with scholars based in Austria, United States and Italy. Klaus Seppi's co-authors include Werner Poewe, Gregor K. Wenning, Glenda M. Halliday, Anette Schrag, Anthony E. Lang, Caroline M. Tanner, Jens Volkmann, Patrik Brundin, Michael Schocke and Cristina Sampaio and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Klaus Seppi

285 papers receiving 20.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Parkinson disease

2017 3.3k citations Werner Poewe, Klaus Seppi et al. profile →
Second consensus statement on the diagnosis of multiple system atrophy

2008 2.3k citations Gregor K. Wenning, David J. Brooks et al. profile →
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease

2011 866 citations Klaus Seppi, Daniel Weintraub et al. Movement Disorders profile →
International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease

2018 668 citations Klaus Seppi et al. Movement Disorders profile →
Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

2019 647 citations Klaus Seppi, Daniel Weintraub et al. Movement Disorders profile →
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

2011 387 citations Klaus Seppi, Werner Poewe et al. Movement Disorders profile →
Multiple system atrophy

2022 138 citations Werner Poewe, Iva Stanković et al. profile →
European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies

2022 100 citations Günther Deuschl, Angelo Antonini et al. Movement Disorders profile →

Peers

Countries citing papers authored by Klaus Seppi

Since Specialization

Citations

This map shows the geographic impact of Klaus Seppi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Seppi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Seppi more than expected).

Fields of papers citing papers by Klaus Seppi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Seppi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Seppi. The network helps show where Klaus Seppi may publish in the future.

Co-authorship network of co-authors of Klaus Seppi

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Seppi. A scholar is included among the top collaborators of Klaus Seppi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Seppi. Klaus Seppi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trajectories of Pontine Volume in Patients with Multiple System Atrophy 2025 ·Movement Disorders ·Kazuya Kawabata, Florian Krismer, Mizuki Ito, Kazuhiro Hara, Epifanio Bagarinao, Vincent Beliveau, Patrice Péran, (unknown), Anne Pavy‐Le Traon, Wassilios G. Meissner, Alexandra Foubert‐Samier, Margherita Fabbri, Mark Forrest Gordon, Aya Ogura, Masahisa Katsuno, Olivier Rascol, Christoph Scherfler, Klaus Seppi, Hirohisa Watanabe, Werner Poewe	1
2	Classification of Parkinson’s disease and isolated REM sleep behaviour disorder: delineating progression markers from the sebum volatilome 2025 ·npj Parkinson s Disease ·Caitlin Walton‐Doyle, Beatrice Heim, Eleanor Sinclair, (unknown), Katherine A. Hollywood, Joy Milne, Evi Holzknecht, Ambra Stefani, Birgit Högl, Klaus Seppi, Monty Silverdale, Werner Poewe, Perdita E. Barran, Drupad K. Trivedi	1
3	Delayed orthostatic hypotension in Parkinson’s disease and in the general ageing population 2025 ·Age and Ageing ·(unknown), (unknown), (unknown), (unknown), Giulia Rivasi, Hans H. Goebel, Giuseppe Dario Testa, Roberta Granata, Susanne Dürr, Jean‐Pierre Ndayisaba, (unknown), (unknown), Klaus Seppi, Werner Poewe, Stefan Kiechl, Andrea Ungar, Gregor K. Wenning, Martina Rafanelli, Alessandra Fanciulli	0
4	Protocol for olfactory training in persisting COVID-19-associated loss of smell (SMELL): a monocentric randomised controlled trial conducted in Innsbruck 2025 ·BMJ Open ·(unknown), (unknown), Joachim Schmutzhard, (unknown), Marina Peball, Atbin Djamshidian, (unknown), Hans H. Goebel, Raimund Helbok, (unknown), Judith Löffler‐Ragg, Günter Weiß, Klaus Seppi, Beatrice Heim	1
5	Effects of physiotherapy and home-based training in parkinsonian syndromes: protocol for a randomised controlled trial (MobilityAPP) 2024 ·BMJ Open ·Cecilia Raccagni, (unknown), Anisoara Paraschiv-Ionescu, Nils Roth, (unknown), Bjoern M. Eskofier, Heiko Gaßner, Felix Kluge, Francesco Teatini, Klaus Seppi, Hans H. Goebel, David Benninger, Kamiar Aminian, Jochen Klucken, Gregor K. Wenning	3
6	Longitudinal brain changes in Parkinson's disease with severe olfactory deficit 2024 ·Parkinsonism & Related Disorders ·Kazuya Kawabata, Epifanio Bagarinao, Klaus Seppi, Werner Poewe	5
7	Long‐Term Medication Profiles in Parkinson's Disease under Subthalamic Deep Brain Stimulation: A Controlled Study 2024 ·Movement Disorders Clinical Practice ·(unknown), Vincent Beliveau, Florian Krismer, Marina Peball, Katherina Mair, Beatrice Heim, Atbin Djamshidian, Stefan Kiechl, Wilhelm Eisner, Sabine Eschlböck, Gregor K. Wenning, Peter Willeit, Klaus Seppi, Werner Poewe, Philipp Mahlknecht	1
8	Early Screening for the Parkinson Variant of Multiple System Atrophy: A 6‐Item Score 2024 ·Movement Disorders Clinical Practice ·Alessandra Fanciulli, Iva Stanković, (unknown), Milica Ječmenica‐Lukić, (unknown), (unknown), Hans H. Goebel, Florian Krismer, Igor Petrović, Marina Svetel, Klaus Seppi, Vladimir Kostić, Nir Giladi, Werner Poewe, Gregor K. Wenning, Tanya Gurevich	1
9	α‐Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid—A Systematic Review and Meta‐Analysis 2023 ·Movement Disorders Clinical Practice ·(unknown), (unknown), Florian Krismer, Marina Peball, Atbin Djamshidian, Werner Poewe, Klaus Seppi, Beatrice Heim	55
10	Cognitive dysfunction in de novo Parkinson disease: Remitting vs. progressive cognitive impairment 2023 ·Parkinsonism & Related Disorders ·Kazuya Kawabata, Atbin Djamshidian, Epifanio Bagarinao, Daniel Weintraub, Klaus Seppi, Werner Poewe	4
11	Development and Validation of a Prognostic Model to Predict Overall Survival in Multiple System Atrophy 2023 ·Movement Disorders Clinical Practice ·Sabine Eschlboeck, Hans H. Goebel, (unknown), Alessandra Fanciulli, Cecilia Raccagni, Sylvia Boesch, Atbin Djamshidian, Beatrice Heim, Philipp Mahlknecht, Katherina Mair, Wolfgang Nachbauer, Christoph Scherfler, Heike Stockner, Werner Poewe, Klaus Seppi, Stefan Kiechl, Gregor K. Wenning, Florian Krismer, (unknown)	4
12	Progressive Brain Atrophy in Multiple System Atrophy: A Longitudinal, Multicenter, Magnetic Resonance Imaging Study 2023 ·Movement Disorders ·Florian Krismer, Patrice Péran, Vincent Beliveau, Klaus Seppi, (unknown), Anne Pavy‐Le Traon, Wassilios G. Meissner, Alexandra Foubert‐Samier, Margherita Fabbri, Michael Schocke, Mark Forrest Gordon, Gregor K. Wenning, Werner Poewe, Olivier Rascol, Christoph Scherfler	12
13	Temporal Muscle Thickness Correlates with Sarcopenia in Parkinson’s Disease 2023 ·Journal of Parkinson s Disease ·Marina Peball, (unknown), (unknown), Kathrin Marini, (unknown), (unknown), Florian Krismer, Atbin Djamshidian, Klaus Seppi, Beatrice Heim	11
14	Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational study 2022 ·Acta Neurologica Scandinavica ·Alfonso Fasano, Victor S.C. Fung, Klaus Seppi, Zvezdan Pirtošek, Annamária Takáts, Ali Alobaidi, Koray Onuk, Lars Bergmann, Juan Carlos Parra, Bülent Elibol	7
15	European Academy of Neurology/Movement Disorder Society‐European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies breakdown → 2022 ·Movement Disorders ·Günther Deuschl, Angelo Antonini, João Costa, Katarzyna Śmiłowska, Daniela Berg, Jean‐Christophe Corvol, Giovanni Fabbrini, Joaquim J. Ferreira, Thomas Foltynie, Pablo Mir, Anette Schrag, Klaus Seppi, Pille Taba, Evžen Růžička, Marianna Selikhova, Nicholas Henschke, Gemma Villanueva, Elena Moro	100
16	European Academy of Neurology/Movement Disorder Society ‐ European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies 2022 ·European Journal of Neurology ·Günther Deuschl, Angelo Antonini, João Costa, Katarzyna Śmiłowska, Daniela Berg, Jean‐Christophe Corvol, Giovanni Fabbrini, Joaquim J. Ferreira, Thomas Foltynie, Pablo Mir, Anette Schrag, Klaus Seppi, Pille Taba, Evžen Růžička, Marianna Selikhova, Nicholas Henschke, Gemma Villanueva, Elena Moro	48
17	Automated segmentation of deep brain nuclei using convolutional neural networks and susceptibility weighted imaging 2021 ·Human Brain Mapping ·Vincent Beliveau, Martin Nørgaard, Christoph Birkl, Klaus Seppi, Christoph Scherfler	16
18	A Standardized MR Imaging Protocol for Parkinsonism 2020 ·Movement Disorders ·Sofia Reimão, (unknown), Klaus Seppi, Joaquim J. Ferreira, Werner Poewe	7
19	Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study 2020 ·Movement Disorders ·Salvatore Nigro, Angelo Antonini, David E. Vaillancourt, Klaus Seppi, Roberto Ceravolo, Antonio P. Strafella, Antonio Augimeri, Andrea Quattrone, Maurizio Morelli, Luca Weis, Eleonora Fiorenzato, Roberta Biundo, Roxana G. Burciu, Florian Krismer, Nikolaus R. McFarland, Christoph Mueller, Elke R. Gizewski, Mirco Cosottini, Eleonora Del Prete, Sonia Mazzucchi, (unknown), (unknown)	35
20	Second consensus statement on the diagnosis of multiple system atrophy 2008 ·UCL Discovery (University College London) ·Sid Gilman, Gregor K. Wenning, (unknown), David J. Brooks, CJ Mathias, (unknown), Nicholas Wood, Cesare Colosimo, A. Dürr, CJ Fowler, Horacio Kaufmann, Thomas Klockgether, A. J. Lees, Werner Poewe, (unknown), Tamás Révész, David Robertson, Paola Sandroni, Klaus Seppi, M Vidailhet	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact